| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in TARS over the last quarter tilts toward selling: insiders offloaded a net 62,595 shares worth roughly $5.2M.
TARS sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 828.0K | $75.57M | - | |
| Dir | 95.3K | $7.47M | - | |
| COO | 78.5K | $6.68M | - | |
| Other | 64.0K | $4.29M | - | |
| Other | 61.5K | $4.12M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 9, 2025 | Mottiwala Aziz51 | Chief Commercial Officer | Sell | 17,500 | $43.76 | $765,800.00 | -26.9% | +32.0% | - | |
| Mar 24, 2025 | Azamian Bobak R.45 | President/ CEO And Board Chair | Sell | 6,000 | $50.00 | $300,000.00 | -0.7% | -22.5% | +20.6% | |
| Mar 20, 2025 | Whitfield Dianne C. | Chief Human Resources Officer | Sell | 6,711 | $47.88 | $321,323.02 | -12.6% | -17.7% | +29.3% | |
| Mar 20, 2025 | Farrow Jeffrey S | See Remarks | Sell | 3,724 | $47.88 | $178,306.42 | -14.2% | -17.7% | +29.3% | |
| Mar 20, 2025 | Azamian Bobak R.45 | President/ CEO And Board Chair | Sell | 24,216 | $48.03 | $1,163,050.13 | -31.1% | -17.7% | +29.3% | |
| Mar 20, 2025 | Wahl Bryan | General Counsel | Sell | 9,686 | $47.88 | $463,765.53 | -15.8% | -17.7% | +29.3% | |
| Mar 20, 2025 | Neervannan Seshadri | Chief Operating Officer | Sell | 7,583 | $47.89 | $363,141.50 | -8.7% | -17.7% | +29.3% | |
| Mar 20, 2025 | Mottiwala Aziz51 | Chief Commercial Officer | Sell | 10,565 | $47.88 | $505,856.42 | -14.0% | -17.7% | +29.3% | |
| Aug 12, 2024 | Link William J Phd | Director | Sell | 35,000 | $26.08 | $912,960.92 | -100% | +87.3% | +96.0% | |
| Jun 18, 2024 | Farrow Jeffrey S | See Remarks | Sale+OE | 10,445 | $27.47 | $286,924.15 | -36.5% | +16.9% | +50.5% |